BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23207870)

  • 1. Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window.
    Zhang L; Lapierre A; Roy B; Lim M; Zhu J; Wang W; Sampson SB; Yun K; Lyons B; Li Y; Lin DT
    J Vis Exp; 2012 Nov; (69):. PubMed ID: 23207870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
    Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
    Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
    Filatova A; Acker T; Garvalov BK
    Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.
    Cheng L; Huang Z; Zhou W; Wu Q; Donnola S; Liu JK; Fang X; Sloan AE; Mao Y; Lathia JD; Min W; McLendon RE; Rich JN; Bao S
    Cell; 2013 Mar; 153(1):139-52. PubMed ID: 23540695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dystroglycan receptor maintains glioma stem cells in the vascular niche.
    Day BW; Lathia JD; Bruce ZC; D'Souza RCJ; Baumgartner U; Ensbey KS; Lim YC; Stringer BW; Akgül S; Offenhäuser C; Li Y; Jamieson PR; Smith FM; Jurd CLR; Robertson T; Inglis PL; Lwin Z; Jeffree RL; Johns TG; Bhat KPL; Rich JN; Campbell KP; Boyd AW
    Acta Neuropathol; 2019 Dec; 138(6):1033-1052. PubMed ID: 31463571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
    Jhaveri N; Chen TC; Hofman FM
    Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model.
    Adjei-Sowah EA; O'Connor SA; Veldhuizen J; Lo Cascio C; Plaisier C; Mehta S; Nikkhah M
    Adv Sci (Weinh); 2022 Jul; 9(21):e2201436. PubMed ID: 35619544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
    Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
    Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-chip perivascular
    Gerigk M; Bulstrode H; Shi HH; Tönisen F; Cerutti C; Morrison G; Rowitch D; Huang YYS
    Lab Chip; 2021 Jun; 21(12):2343-2358. PubMed ID: 33969368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.